drugset / Trial / NCT07444385

A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

NCT07444385

Phase 1 Recruiting 44 enrolled Addpharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 Under Fed Conditions in Healthy Adult Male Subjects

Timeline

Start
2026-02-26
Primary completion
2026-04-22
Completion
2026-05-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dutasteride Small molecule 0.5 mg Oral
Subject Tamsulosin Other / unclassified 0.4 mg Oral